{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:41:23Z","timestamp":1740138083101,"version":"3.37.3"},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":362,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1002\/jcph.383","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T19:29:15Z","timestamp":1408562955000},"page":"137-143","source":"Crossref","is-referenced-by-count":2,"title":["Non-obligatory role of prostaglandin D2 receptor subtype 1 in rosacea: Laropiprant in Comparison to a placebo did not alleviate the symptoms of erythematoelangiectaic rosacea"],"prefix":"10.1002","volume":"55","author":[{"given":"Rajesh","family":"Krishna","sequence":"first","affiliation":[{"name":"Merck, Sharp and Dohme Corporation; a subsidiary of Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[{"name":"Merck, Sharp and Dohme Corporation; a subsidiary of Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Schulz","sequence":"additional","affiliation":[{"name":"Merck, Sharp and Dohme Corporation; a subsidiary of Merck & Co., Inc.; Whitehouse Station NJ USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evyan","family":"Cord-Cruz","sequence":"additional","affiliation":[{"name":"Symbio LLC; Port Jefferson NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanna","family":"Smith","sequence":"additional","affiliation":[{"name":"Symbio LLC; Port Jefferson NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Hair","sequence":"additional","affiliation":[{"name":"Symbio LLC; Port Jefferson NY USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter K.","family":"Nahm","sequence":"additional","affiliation":[{"name":"Division of Dermatology; University of California, School of Medicine; San Diego CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe D.","family":"Draelos","sequence":"additional","affiliation":[{"name":"Dermatology Consulting Services; High Point NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,4]]},"reference":[{"issue":"3","key":"10.1002\/jcph.383-BIB0001|jcph383-cit-0001","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea 1. Etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/jcph.383-BIB0002|jcph383-cit-0002","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing","volume":"115","author":"Beny\u00f3","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1002\/jcph.383-BIB0003|jcph383-cit-0003","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0090-6980(84)90033-9","article-title":"Effects of intravenous infusions of prostaglandin D2 in man","volume":"28","author":"Heavey","year":"1984","journal-title":"Prostaglandins"},{"key":"10.1002\/jcph.383-BIB0004|jcph383-cit-0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-6980(89)90088-9","article-title":"Release of markedly increased quantities of prostaglandin D2in vivo in humans following the administration of nicotinic acid","volume":"38","author":"Morrow","year":"1989","journal-title":"Prostaglandins"},{"issue":"Series B","key":"10.1002\/jcph.383-BIB0005|jcph383-cit-0005","first-page":"134","article-title":"Longitudinal data analysis of continuous and discrete responses for pre-post designs","volume":"62","author":"Liang","year":"2000","journal-title":"Sankhya: Indian J Stat"},{"key":"10.1002\/jcph.383-BIB0006|jcph383-cit-0006","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1002\/jcph.383-BIB0007|jcph383-cit-0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1468-3083.1997.tb00196.x","article-title":"Flushing: causes, investigation and clinical consequences","volume":"8","author":"Greaves","year":"1997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1002\/jcph.383-BIB0008|jcph383-cit-0008","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0190-9622(88)70177-2","article-title":"Why is flushing limited to a mostly facial cutaneous distribution","volume":"19","author":"Wilkin","year":"1988","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1002\/jcph.383-BIB0009|jcph383-cit-0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1067\/mjd.2001.113694","article-title":"Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans after application of cinnamic aldehyde","volume":"45","author":"VanderEnde","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1002\/jcph.383-BIB0010|jcph383-cit-0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0009-9236(95)90214-7","article-title":"Topical benzoic acid induces the increased biosynthesis of prostaglandin D2 in human skin in vivo","volume":"57","author":"Downard","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1002\/jcph.383-BIB0011|jcph383-cit-0011","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/archderm.1994.01690110074010","article-title":"Release of markedly increased quantities of prostaglandin D2 from the skin in vivo in humans following application of sorbic acid","volume":"130","author":"Morrow","year":"1994","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1002\/jcph.383-BIB0012|jcph383-cit-0012","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of the skin as a major site of prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1002\/jcph.383-BIB0013|jcph383-cit-0013","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2133.1990.tb01476.x","article-title":"Immediate contact reactions to chemicals in the fragrance mix and a study of the quenching action of eugenol","volume":"123","author":"Safford","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1002\/jcph.383-BIB0014|jcph383-cit-0014","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.4049\/jimmunol.143.9.2982","article-title":"The major source of endogenous prostaglandin D2 is likely antigenpresenting cells: localization of glutathione requiring PGD synthetase in histiocytes, dendritic and Kupffer cells in various rat tissues","volume":"143","author":"Urade","year":"1989","journal-title":"J Immunol"},{"key":"10.1002\/jcph.383-BIB0015|jcph383-cit-0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00403-007-0816-z","article-title":"A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process","volume":"300","author":"Aroni","year":"2008","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1002\/jcph.383-BIB0016|jcph383-cit-0016","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.clpt.6100345","article-title":"Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist","volume":"83","author":"Lai","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1002\/jcph.383-BIB0017|jcph383-cit-0017","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00228-006-0211-2","article-title":"The effect of laropiprant, a prostaglandin D(2) receptor antagonist, on prostaglandin D (2)-induced nasal airway obstruction in healthy volunteers","volume":"63","author":"Van Hecken","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1002\/jcph.383-BIB0018|jcph383-cit-0018","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/sj.clpt.6100180","article-title":"Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1","volume":"81","author":"Lai","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"17","key":"10.1002\/jcph.383-BIB0019|jcph383-cit-0019","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1073\/pnas.0601574103","article-title":"Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans","volume":"103","author":"Cheng","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1002\/jcph.383-BIB0020|jcph383-cit-0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2353\/ajpath.2010.090111","article-title":"Dendritic cells express hematopoietic prostaglandin D synthase and function as a source of prostaglandin D2 in the skin","volume":"176","author":"Shimura","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1002\/jcph.383-BIB0021|jcph383-cit-0021","article-title":"Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH","author":"Cotsarelis","year":"2011","journal-title":"US Patent US 20110021599 A1"},{"key":"10.1002\/jcph.383-BIB0022|jcph383-cit-0022","unstructured":"Tan J Liu H Leyden JJ Leoni MJ http:\/\/www.jaad.org\/article\/S0190-9622(14) 01532-1\/fulltext"},{"key":"10.1002\/jcph.383-BIB0023|jcph383-cit-0023","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","article-title":"Once-daily topical brimonidine tartrate gel 0AE5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies","volume":"166","author":"Fowler","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1002\/jcph.383-BIB0024|jcph383-cit-0024","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1742-1241.2008.01739.x","article-title":"Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire: results from a randomised placebo-controlled clinical trial","volume":"62","author":"Paolini","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1002\/jcph.383-BIB0025|jcph383-cit-0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0738-081X(98)00061-3","article-title":"Placebo therapy in dermatology","volume":"17","author":"Barfod","year":"1999","journal-title":"Clinics Dermatol"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.383","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcph.383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T04:40:57Z","timestamp":1689482457000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcph.383"}},"subtitle":["No role for DP1 in rosacea"],"short-title":[],"issued":{"date-parts":[[2014,9,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1002\/jcph.383","relation":{},"ISSN":["0091-2700"],"issn-type":[{"type":"print","value":"0091-2700"}],"subject":[],"published":{"date-parts":[[2014,9,4]]}}}